About us

curasan develops, produces and markets biomaterials and medical devices for bone and tissue regeneration.

As a global technology leader in the future-oriented growth market of regenerative medicine, our company is specialized in biomimetic bone grafting materials (i.e. materials mimicking biological structures) for the use in orthopedics, traumatology, spine surgery and dental implantology.

Under the CERASORB® brand we offer an innovative product pipeline for bone and tissue regeneration. The phase purity of the beta-tricalcium phosphate used in CERASORB® is considered the global reference standard* in the market.  Numerous product forms, ranging from granules and pastes to tailor-made block forms and mouldable collagen sponges, give surgeons and implantologists maximum flexibility.

Other areas of application in our product range include innovative products for are wound healing and osteoarthritis therapy. Our products are the products of choice for orthopedic, trauma and spine surgeons, sports medicine specialists, implantologists, oral and maxillofacial surgeons and specialists in dental surgery.

As an industry pioneer we have the best research teams and development engineers in the industry and are proud of the numerous patents obtained in more than 30 years of company history.  Extensive scientific documentation demonstrates the clinical success of our products and our outstanding capacity for innovation. This we assure in our own high-tech research, development and production facility in Frankfurt/Main, Germany, where our technological equipment meets the highest standards.

Top quality is our top priority. Based on these principles, we continuously develop and optimize our products in order to offer premium products that promote successful clinical results. This is our contribution to safe and sustainable treatment therapies.

In addition to its headquarters, the company has a subsidiary, curasan, Inc., in Wake Forest, near Raleigh, N.C., USA. Our innovative products are cleared by the US Food and Drug Administration (FDA) and many other international authorities and are available in almost 50 countries worldwide. They are marketed by a global network of selected premium distributors.

 *International Center of Diffraction Data, USA, ICDD 55-898

Sustainability

History

Code of Conduct